Literature DB >> 12414431

Lymphoma-associated retinopathy.

King W To1, Charles E Thirkill, Frederick A Jakobiec, Simmons Lessell, Eliot L Berson.   

Abstract

OBJECTIVE: To describe the clinical, electrophysiologic, and serologic findings in a patient with retinal degeneration associated with Hodgkin's lymphoma.
DESIGN: Case report with ancillary immunohistochemical studies.
METHODS: A 24-year-old woman experienced night blindness and fundus abnormalities 1 week after initiation of chemotherapy for Hodgkin's lymphoma. Visual fields and full-field electroretinograms (ERGs) were monitored over a 10-year period. Serum antibodies were studied on Western blot reactions on a solubilized extract of bovine retina. Serum antibodies were also evaluated through indirect immunohistochemistry on rhesus monkey retina.
RESULTS: Visual field and ERG amplitudes, initially abnormal, became reduced further over 10 years. Serum antibodies were identified that reacted to a retinal protein or proteins approximating 65 kd; these antibodies showed immunologic activity against photoreceptors.
CONCLUSIONS: A progressive paraneoplastic retinopathy can occur in association with Hodgkin's lymphoma. The pathogenesis of the retinal degeneration appears to be related to a serum antibody that is reacting to a retinal protein or proteins of approximately 65 kd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414431     DOI: 10.1016/s0161-6420(02)01261-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  A denileukin diftitox (Ontak) associated retinopathy?

Authors:  J B Ruddle; C A Harper; D Hönemann; J F Seymour; H M Prince
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

Review 2.  Ophthalmic Manifestations of Hodgkin Lymphoma: A Review.

Authors:  Juan Valenzuela; Jose J Echegaray; Emilio Dodds; Shree K Kurup; Careen Lowder; Sarah L Ondrejka; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2021-08-17

3.  Iris pigment epithelial (IPE) cysts secondary to Hodgkin's lymphoma: A case report.

Authors:  Elien Willekens; Veva De Groot; Karolien Beel; Kim De Muynck; Pieter-Paul Schauwvlieghe
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-02

4.  Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Authors:  Ying Lu; Lin Jia; Shirley He; Mary C Hurley; Monique J Leys; Thiran Jayasundera; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-12

5.  Beneath the Retinal Pigment Epithelium: Histopathologic Findings in Metastatic Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

Authors:  Atalie C Thompson; Chad M McCall; Alan D Proia
Journal:  Ocul Oncol Pathol       Date:  2018-06-06

Review 6.  Paraneoplastic syndromes in patients with primary head and neck cancer.

Authors:  Alfio Ferlito; Mohamed N Elsheikh; Johannes J Manni; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-06       Impact factor: 3.236

7.  Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature.

Authors:  Marcus Vetter; Alexandar Tzankov; Andreas Engert; Matthias Mehling; Richard Herrmann; Christoph Rochlitz
Journal:  Case Rep Oncol       Date:  2011-02-25

8.  Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) associated with B-cell lymphoma: report of a rare case.

Authors:  Maria Pefkianaki; Rupesh Agrawal; Parul Desai; Carlos Pavesio; Mandeep S Sagoo
Journal:  BMC Cancer       Date:  2015-01-30       Impact factor: 4.430

9.  Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy.

Authors:  Gunay Uludag; Sumru Onal; Serra Arf; Isil Sayman Muslubas; Fatih Selcukbiricik; Aylin Koc Akbay; Nil Molinas Mandel
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-30

10.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.